Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

SKB's anti-IL-5 MAb in preclinical testing for asthma

May 17, 1996

NK1/NK2 antagonist MDL-105212: Potential antiasthmatic

May 17, 1996

Takeda claims NK1 ligands for respiratory indications

May 17, 1996

PDE IV inhibitor SB-207499 in phase II

May 17, 1996

Byk Gulden reports PDE IV inhibitors for asthma, dermatoses

May 17, 1996

Pentoxifylline claimed for treating cold symptoms

May 17, 1996

R-844: Novel steroid for asthma

May 10, 1996

Glaxo Wellcome's newest approach to ARDS

May 3, 1996

Arris announces preliminary results for APC-366

May 3, 1996

Rupatadine poised to enter phase II

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 21, 2025.
Coinfections and diversity paint the many shades of HIV cure
BioWorld
We all look different to HIV, a virus that destroys the immune system. The defensive cells record every interaction with foreign agents, infections from viruses...
Livzon’s IL-17A/F meets phase III endpoints in plaque psoriasis
BioWorld
Livzon Mabpharm Inc.’s anti-IL-17A/F monoclonal antibody, LZM-012, met the primary endpoint in a phase III trial in moderate to severe plaque psoriasis. Conducted...
Sino to acquire Lanova and pipeline for up to $950M
BioWorld Asia
Sino Biopharmaceutical Ltd. agreed to fully acquire Lanova Medicines Ltd. by buying an additional 95.09% stake in Lanova at a valuation of up to $950.92 million....